RareResearch.AI
← Back to atlas

G437R

Category 3/4 — Most DruggablePathogenic/Likely pathogenicTransmembrane · predictedEditorial
GlycineArginine at position 437 · TM4 (427-447), helical transmembrane · WFS1 (Wolframin)

A buried glycine in transmembrane helix TM4 is replaced by arginine — the bilayer interior has no business hosting a fully solvated guanidinium, and the helix packing against TM5 collapses.

Interactive 3D Structure

Wild-type reference
Wild-type G437 — hydrogen bond to V441
Fullscreen ↗
DynaMut2 mutant · G437R
Mutant R437 — energy-minimized; 2 new contacts formed
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

0 lost2 gained7 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondA433A433Preserved
Hydrogen bondT440T440Preserved
Hydrogen bondV441V441Preserved
Polar contactA433A433Preserved
Polar contactV434V434Preserved
Polar contactI435Gained
Polar contactT440T440Preserved
Polar contactV441V441Preserved
Van der WaalsI435Gained

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.59kcal/mol
Destabilising — mild
AlphaMissense
0.935
LPath
AlphaFold pLDDT
90
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationPathogenic/Likely pathogenic
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1
InheritanceAutosomal recessive (Wolfram syndrome 1).
Population frequency (gnomAD v4)Ultra-rare · AF 0.0033%
cDNA changec.1309G>C
ClinVar accessionVCV001199427
Last evaluated2025/08/30 00:00

Observed at very low frequency in gnomAD.

Structural Context

G437 sits inside TM4's helical core, with Thr436 (2.46 Angstrom) and Phe438 (2.46 Angstrom) as covalent neighbors. The through-space cluster is dense and hydrophobic: Ala433 (3.68 Angstrom), Ser544 (3.80 Angstrom) — note that Ser544 is on a neighboring helix or loop, indicating an inter-helix contact — Val434 (3.83 Angstrom), Thr440 (4.13 Angstrom), Ile435 (4.41 Angstrom), Phe439 (4.42 Angstrom). The wild-type glycine occupies the position where TM4 meets its partner helix; only glycine is small enough to allow that close approach.

Substituting arginine here is a near-worst-case lipid-bilayer mutation. Arginine's guanidinium group carries a delocalized positive charge and requires solvation — typically by water or by phosphate headgroups at the membrane interface. Burying it in the middle of TM4 forces one of two outcomes: either the guanidinium snorkels upward toward the lipid headgroups, dragging the helix backbone out of register, or it remains buried at a substantial desolvation cost (estimated 8-12 kcal/mol for an ionized arginine in low dielectric). Both outcomes destabilize the helix-helix interface that requires glycine's small footprint.

DynaMut2's DeltaDeltaG of -0.59 kcal/mol substantially underestimates the cost, because the energy function does not fully capture transmembrane desolvation. AlphaMissense at 0.935 reads the true severity: G437R is essentially incompatible with normal TM4 packing. The structural prediction is that TM4 either ejects from its native register against TM5 or that the protein fails to insert into the membrane co-translationally — exactly the kind of misfolding that triggers ER retention and ER-associated degradation.

ClinVar records this variant for Wolfram syndrome 1 — consistent with a classical loss-of-function mechanism via misfolding and degradation.

Amino-acid chemistry
Glycine (no side chain, smallest residue, the only amino acid that fits inside tightly packed helix-helix interfaces) to Arginine (large, positively charged, fully solvated guanidinium group with substantial desolvation penalty in apolar environments) at position 437.
Position in the protein
Position 437 sits inside transmembrane helix TM4 (residues 427-447). This is one of the eleven TM helices that anchor wolframin in the ER membrane; the residue is buried in the hydrophobic bilayer interior and packs against neighboring helices. pLDDT 90.31 confirms an ordered, well-modeled region.

Druggability Assessment

Final classification: Category 3 — Most Druggable, with a caveat. The schema places G437R in the small-magnitude DeltaDeltaG bucket, but the true thermodynamic cost of a buried guanidinium in TM4 is likely much larger than DynaMut2 reports. The convergent evidence — high AlphaMissense (0.935), bilayer-interior placement, glycine-only geometric constraint — argues this variant behaves more like Category 2 (pharmacological chaperone) or even Category 1 (gene therapy) in practice. For docking and small-molecule design, G437R is a hard target: the lesion is buried in the membrane, and the rescue molecule would need to occupy the inter-helix interface that TM4 normally packs against. Pharmacological chaperones that bind the unfolded form and stabilize TM4 insertion are the more plausible route. For severe carriers, AAV-delivered wild-type WFS1 should be on the table as a parallel track. The Atlas should flag this variant as one where the DeltaDeltaG number under-reads the biology.

Why this matters

G437R is a useful counterexample to the schema's strict ΔΔG bucketing. The published energy function calls it mild; the chemistry calls it severe. Glycine-to-arginine substitutions in transmembrane helices are among the most-disruptive single-residue swaps known — the literature on CFTR, rhodopsin, and aquaporins is consistent on this point. The Atlas should treat such substitutions as exceptions where a structural-chemistry override is warranted. For the wolframin program more broadly, identifying the TM helix glycines is high-leverage: each one is a potential severe-variant locus, and any therapeutic that recovers TM packing for one likely generalizes to others. This is the same logic that drove the CFTR field toward correctors like lumacaftor and tezacaftor.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the G437R PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download G437R PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin
Transmembrane427447 · Helical
Natural variant437437 · in WFS1; dbSNP:rs147974629